AC
CLDI.WS
Aristeia Capital’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-494,400
| Closed | -$6.9K | – | 494 |
|
|
2024
Q3 | $6.9K | Hold |
494,400
| – | – | ﹤0.01% | 339 |
|
|
2024
Q2 | $17.3K | Hold |
494,400
| – | – | ﹤0.01% | 280 |
|
|
2024
Q1 | $27.2K | Hold |
494,400
| – | – | ﹤0.01% | 219 |
|
|
2023
Q4 | $31.9K | Hold |
494,400
| – | – | ﹤0.01% | 121 |
|
|
2023
Q3 | $116K | Hold |
494,400
| – | – | ﹤0.01% | 96 |
|
|
2023
Q2 | $59K | Hold |
494,400
| – | – | ﹤0.01% | 149 |
|
|
2023
Q1 | $24.3K | Sell |
494,400
-600
| -0.1% | -$30 | ﹤0.01% | 289 |
|
|
2022
Q4 | $24.8K | Hold |
495,000
| – | – | ﹤0.01% | 392 |
|
|
2022
Q3 | $26K | Hold |
495,000
| – | – | ﹤0.01% | 539 |
|
|
2022
Q2 | $47K | Hold |
495,000
| – | – | ﹤0.01% | 518 |
|
|
2022
Q1 | $165K | Buy |
+495,000
| New | +$165K | ﹤0.01% | 470 |
|